Anti-CXCL9 抗体
Anti-CXCL9 antibody
4
(2 Reviews)
|
(12 Publications)
Rabbit Polyclonal CXCL9 antibody. Suitable for ELISA, WB, sELISA, IHC-P and reacts with Recombinant full length protein - Human, Human samples. Cited in 12 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human CXCL9.
別名を表示する
CMK, MIG, SCYB9, CXCL9, C-X-C motif chemokine 9, Gamma-interferon-induced monokine, Monokine induced by interferon-gamma, Small-inducible cytokine B9, HuMIG
- sELISA
Unknown
Sandwich ELISA - Anti-CXCL9 antibody (AB9720)
Detection of hMIG (human Monokine induced by Interferon-Gamma) by sandwich ELISA (100 μl/well antibody solution). ab9720 as a detection antibody, allows the detection of at least 0.2 - 0.4 ng/well of recombinant hMIG.
Reactivity data
製品の詳細
出荷温度及び保存条件
製品の状態
再構成
精製方法
出荷温度
短期保存期間
短期保存温度
長期保存温度
分注に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This cytokine plays a pivotal role in the immune system by regulating leukocyte trafficking. CXCL9 exerts its function through binding to the CXCR3 receptor attracting T cells towards sites of inflammation or infection. This interaction is significant in mediating immune surveillance and host defense. CXCL9 does not form part of a larger protein complex but its chemokine activity is critical for immune system coordination. Scientific studies often highlight its involvement through CXCL9 function and expression analysis.
Pathways
CXCL9 significantly influences the chemokine signaling pathway and the Th1-type adaptive immune response. Within these pathways it interacts closely with other chemokines like CXCL10 and CXCL11 which also bind to the CXCR3 receptor. These pathways highlight the coordinated mobilization of T cells during immune challenges and inflammation emphasizing how CXCL9 is often examined alongside these related chemokines in research settings.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (12)
Recent publications for all applications. Explore the full list and refine your search
JCI insight 9: PubMed39190494
2024
Applications
Unspecified application
Species
Unspecified reactive species
Experimental & molecular medicine 55:1713-1719 PubMed37524866
2023
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8:2002497 PubMed33643790
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular immunology 128:287-297 PubMed33248399
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer science 111:4041-4050 PubMed32860283
2020
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in physiology 11:441 PubMed32528301
2020
Applications
Unspecified application
Species
Unspecified reactive species
Aging 12:5048-5070 PubMed32181755
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 35:885-900.e10 PubMed31185212
2019
Applications
Unspecified application
Species
Unspecified reactive species
Molecular carcinogenesis 58:171-184 PubMed30302818
2018
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 7:13976-83 PubMed26910919
2016
Applications
IHC
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com